4//SEC Filing
Mehra Uneek 4
Accession 0001610717-23-000301
CIK 0001650648other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:17 PM ET
Size
5.6 KB
Accession
0001610717-23-000301
Insider Transaction Report
Form 4
Mehra Uneek
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-10-01+229,634→ 229,634 totalExercise: $12.73Exp: 2033-09-30→ Common Stock (229,634 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the total number of the underlying shares on September 11, 2024, and the remaining shares will vest in equal monthly installments over the following three-year period, such that the stock option will be fully vested on September 11, 2027, subject to the Reporting Person continuing to be a service provider to Issuer through each vesting date.
Documents
Issuer
4D Molecular Therapeutics, Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001881504
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:17 PM ET
- Size
- 5.6 KB